Clinical trial of sustained release methylphenidate for Attention-Deficit-Hyperactivity-Disorder (ADHD) in adult criminal offenders with amphetamine addiction

Addiction Center Stockholm0 个研究点目标入组 54 人开始时间: 2006年6月9日最近更新: 2012年7月3日

适应症

试验速览

暂无简介。

•- male 18 to 65 yrs
•- signed consent
•- meets the criteria for amphetamine addiction and has used amphetamine in minimum 12 times times in the three month period prior to imprisonment
•- meets the DSM-IV criteria for attention deficit hyperactivity disorder - ADHD
•- drug free for two weeks prior to inclusion (documented with urine samples)
•- imprisoned in a Swedish prison (trial is planned to take place in Håga, Södertälje
•- address and phone nr in Stockholm area where person can be reached
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•-- opioid, alcohol, cannabis or benzodiazepine addiction in the last 5 yrs prior to study
•- other serious psychiatric conditions apart from substance abuse/addiction (i.e. dementia, severe depression with suicidal ideation, acute psychotic symptoms, chronic schizophrenic syndrome)
•- ongoing medication with MAO-repressers, benzodiazepines or neuroleptics
•- acute symptoms of withdrawal regardless substance
•- known heart condition
•- history of stroke
•- other severe medical condition (cancer, hypertonic, glaucoma, advanced arteriosclerosis, liver cirrhosis or any medical condition that could mean a risk for the patient)
•- known hypersensibility to methylphenidate
•-hypertension (>160/95)

发起方

Addiction Center Stockholm